SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
OQuinn Daniel

(Last) (First) (Middle)
C/O SCIPLAY CORPORATION
6601 BERMUDA ROAD

(Street)
LAS VEGAS NV 89119

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/10/2021
3. Issuer Name and Ticker or Trading Symbol
SciPlay Corp [ SCPL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Interim CFO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock 557 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) (1) Class A Common Stock 1,688 (1) D
Restricted Stock Units (2) (2) Class A Common Stock 1,688 (2) D
Restricted Stock Units (3) (3) Class A Common Stock 4,000 (3) D
Restricted Stock Units (4) (4) Class A Common Stock 4,723 (4) D
Restricted Stock Units (5) (5) Class A Common Stock 900 (5) D
Restricted Stock Units (6) (6) Class A Common Stock 334 (6) D
Explanation of Responses:
1. The restricted stock units ("RSUs") are scheduled to vest on September 20, 2021 as to 563 shares with the balance scheduled to vest on September 20, 2022 and September 20, 2023 as to 562 shares and 563 shares, respectively. Each RSU converts into a share of class A common stock on a one-for-one basis.
2. The RSUs are scheduled to vest on September 20, 2021 as to 563 shares with the balance scheduled to vest on September 20, 2022 and September 20, 2023 as to 562 shares and 563 shares, respectively. These RSUs were granted subject to achievement of a performance condition, which condition has been achieved. Each RSU converts into a share of class A common stock on a one-for-one basis.
3. The RSUs are scheduled to vest on September 21, 2021 as to 1,000 shares with the balance of 3,000 shares scheduled to vest in equal installments on September 21, 2022 and September 21, 2023 and September 21, 2024. Each RSU converts into a share of class A common stock on a one-for-one basis.
4. These performance-conditioned RSUs will vest based on the achievement of certain performance conditions with respect to the Company's 2021 fiscal year. Each RSU converts into a share of class A common stock on a one-for-one basis.
5. The RSUs are schedule to vest on March 20, 2022 as to 900 shares. Each RSU converts into a share of class A common stock on a one-for-one basis.
6. The RSUs are scheduled to vest on March 20, 2022 as to 167 shares with the balance of 167 shares scheduled to vest on March 20, 2023. Each RSU converts into a share of class A common stock on a one-for-one basis.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Melissa Bengtson, attorney-in-fact for Daniel O'Quinn 08/13/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24


 
POWER OF ATTORNEY
 

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of James Sottile and Melissa Bengtson, signing singly, the undersigned’s true and lawful attorneys-in-fact to:


1.
execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of SciPlay Corporation (the “Company”) , Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;


2.
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 and 5, and any amendments thereto, and timely file such form or report with the Securities and Exchange Commission and any stock exchange or similar authority; and


3.
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney supersedes any Power of Attorney previously granted by the undersigned with respect to the foregoing matters and shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
 

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on this 5th day of August, 2021.



 
/s/ Daniel O’Quinn
 
Daniel O’Quinn